Exane Derivatives Buys SELECT SECTOR SPDR, ISHARES INC, Fiat Chrysler Automobiles NV, Sells ISHARES TRUST, Linde PLC, MSCI SOUTH KOREA ETF

Article's Main Image
Paris, I0, based Investment company Exane Derivatives (Current Portfolio) buys SELECT SECTOR SPDR, ISHARES INC, Fiat Chrysler Automobiles NV, Merck Inc, Qiagen NV, sells ISHARES TRUST, Linde PLC, MSCI SOUTH KOREA ETF, Visa Inc, Alibaba Group Holding during the 3-months ended 2020Q3, according to the most recent filings of the investment company, Exane Derivatives. As of 2020Q3, Exane Derivatives owns 652 stocks with a total value of $312 million. These are the details of the buys and sells.

For the details of EXANE DERIVATIVES's stock buys and sells, go to https://www.gurufocus.com/guru/exane+derivatives/current-portfolio/portfolio

These are the top 5 holdings of EXANE DERIVATIVES
  1. SELECT SECTOR SPDR (XLE) - 550,048 shares, 5.28% of the total portfolio. Shares added by 339.97%
  2. MSCI TAIWAN ETF (EWT) - 272,877 shares, 3.93% of the total portfolio. Shares added by 11.90%
  3. UBS Group AG (UBS) - 46,514 shares, 3.74% of the total portfolio.
  4. ISHARES INC (TUR) - 537,062 shares, 3.40% of the total portfolio. New Position
  5. Fiat Chrysler Automobiles NV (FCAU) - 15,267 shares, 3.30% of the total portfolio.
New Purchase: ISHARES INC (TUR)

Exane Derivatives initiated holding in ISHARES INC. The purchase prices were between $19.24 and $23.87, with an estimated average price of $21.28. The stock is now traded at around $19.92. The impact to a portfolio due to this purchase was 3.4%. The holding were 537,062 shares as of .

New Purchase: Fiat Chrysler Automobiles NV (FCAU)

Exane Derivatives initiated holding in Fiat Chrysler Automobiles NV. The purchase prices were between $9.78 and $12.81, with an estimated average price of $11.12. The stock is now traded at around $12.61. The impact to a portfolio due to this purchase was 2.34%. The holding were 593,172 shares as of .

New Purchase: Cameco Corp (CCJ)

Exane Derivatives initiated holding in Cameco Corp. The purchase prices were between $10.03 and $12.13, with an estimated average price of $10.81. The stock is now traded at around $9.82. The impact to a portfolio due to this purchase was 0.34%. The holding were 103,986 shares as of .

New Purchase: Bunge Ltd (BG)

Exane Derivatives initiated holding in Bunge Ltd. The purchase prices were between $38.23 and $47.61, with an estimated average price of $44.66. The stock is now traded at around $48.66. The impact to a portfolio due to this purchase was 0.33%. The holding were 22,557 shares as of .

New Purchase: Sensient Technologies Corp (SXT)

Exane Derivatives initiated holding in Sensient Technologies Corp. The purchase prices were between $51.12 and $59.39, with an estimated average price of $55.15. The stock is now traded at around $61.37. The impact to a portfolio due to this purchase was 0.28%. The holding were 15,113 shares as of .

New Purchase: L3Harris Technologies Inc (LHX)

Exane Derivatives initiated holding in L3Harris Technologies Inc. The purchase prices were between $159.8 and $185.44, with an estimated average price of $175.44. The stock is now traded at around $174.69. The impact to a portfolio due to this purchase was 0.15%. The holding were 2,786 shares as of .

Added: SELECT SECTOR SPDR (XLE)

Exane Derivatives added to a holding in SELECT SECTOR SPDR by 339.97%. The purchase prices were between $29.95 and $38.58, with an estimated average price of $35.52. The stock is now traded at around $30.56. The impact to a portfolio due to this purchase was 4.08%. The holding were 550,048 shares as of .

Added: Merck & Co Inc (MRK)

Exane Derivatives added to a holding in Merck & Co Inc by 37.97%. The purchase prices were between $76.69 and $86.93, with an estimated average price of $82.09. The stock is now traded at around $80.18. The impact to a portfolio due to this purchase was 0.55%. The holding were 74,679 shares as of .

Added: Qiagen NV (QGEN)

Exane Derivatives added to a holding in Qiagen NV by 427.65%. The purchase prices were between $42.51 and $52.42, with an estimated average price of $48.79. The stock is now traded at around $54.19. The impact to a portfolio due to this purchase was 0.54%. The holding were 75,105 shares as of .

Added: AmerisourceBergen Corp (ABC)

Exane Derivatives added to a holding in AmerisourceBergen Corp by 92958.82%. The purchase prices were between $94.08 and $104.7, with an estimated average price of $99.36. The stock is now traded at around $96.73. The impact to a portfolio due to this purchase was 0.49%. The holding were 15,820 shares as of .

Added: Altria Group Inc (MO)

Exane Derivatives added to a holding in Altria Group Inc by 754.85%. The purchase prices were between $37.93 and $44.04, with an estimated average price of $41.61. The stock is now traded at around $39.80. The impact to a portfolio due to this purchase was 0.43%. The holding were 39,195 shares as of .

Added: Bristol-Myers Squibb Company (BMY)

Exane Derivatives added to a holding in Bristol-Myers Squibb Company by 96.87%. The purchase prices were between $57.43 and $63.64, with an estimated average price of $60.17. The stock is now traded at around $58.45. The impact to a portfolio due to this purchase was 0.35%. The holding were 36,583 shares as of .

Sold Out: ISHARES TRUST (EEM)

Exane Derivatives sold out a holding in ISHARES TRUST. The sale prices were between $40.44 and $45.55, with an estimated average price of $43.87.

Sold Out: MSCI SOUTH KOREA ETF (EWY)

Exane Derivatives sold out a holding in MSCI SOUTH KOREA ETF. The sale prices were between $57.46 and $66.88, with an estimated average price of $62.7.

Sold Out: Visa Inc (V)

Exane Derivatives sold out a holding in Visa Inc. The sale prices were between $189.02 and $216.48, with an estimated average price of $199.76.

Sold Out: VANECK VECTORS ETF TRUST OIL SVCS ETF (OIH)

Exane Derivatives sold out a holding in VANECK VECTORS ETF TRUST OIL SVCS ETF. The sale prices were between $97.37 and $141.91, with an estimated average price of $122.67.

Sold Out: Zoetis Inc (ZTS)

Exane Derivatives sold out a holding in Zoetis Inc. The sale prices were between $137.1 and $165.37, with an estimated average price of $153.48.

Sold Out: New Gold Inc (NGD)

Exane Derivatives sold out a holding in New Gold Inc. The sale prices were between $1.31 and $2.04, with an estimated average price of $1.61.



Here is the complete portfolio of EXANE DERIVATIVES. Also check out:

1. EXANE DERIVATIVES's Undervalued Stocks
2. EXANE DERIVATIVES's Top Growth Companies, and
3. EXANE DERIVATIVES's High Yield stocks
4. Stocks that EXANE DERIVATIVES keeps buying